ContractAcura Pharmaceuticals, Inc • July 28th, 2017 • Pharmaceutical preparations • New York
THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND, EXCEPT AS SET FORTH IN SECTION 5.3 BELOW, MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
SECOND AMENDED AND RESTATED VOTING AGREEMENTVoting Agreement • July 28th, 2017 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This SECOND AMENDED AND RESTATED VOTING AGREEMENT (this “Agreement”) dated as of July 24, 2017 (the “Effective Date”) (as defined below) is by and among Acura Pharmaceuticals, Inc. (f/k/a Halsey Drug Co., Inc.), a New York corporation (the “Company”), Essex Woodlands Health Ventures V, L.P. (“Essex”) and Galen Partners III, LP (“Galen”) and John Schutte (“Schutte”) and is binding on the other testing parties to the Original Agreement (as defined below).
SUBSCRIPTION AGREEMENTSubscription Agreement • July 28th, 2017 • Acura Pharmaceuticals, Inc • Pharmaceutical preparations • New York
This SUBSCRIPTION AGREEMENT (this “Agreement”) is dated as of July 24, 2017, between Acura Pharmaceuticals, Inc., a New York corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
